LifeVantage (NASDAQ:LFVN) Stock Passes Above 200-Day Moving Average - What's Next?

LifeVantage Co. (NASDAQ:LFVN - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $9.09 and traded as high as $13.62. LifeVantage shares last traded at $12.93, with a volume of 122,050 shares traded.

LifeVantage Price Performance

The stock has a 50-day moving average price of $12.28 and a 200-day moving average price of $9.09. The company has a market capitalization of $161.88 million, a P/E ratio of 40.41 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.16 annualized dividend and a yield of 1.24%. LifeVantage's dividend payout ratio is currently 50.00%.

Hedge Funds Weigh In On LifeVantage

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its position in shares of LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company's stock valued at $2,874,000 after acquiring an additional 12,809 shares during the period. Acadian Asset Management LLC boosted its position in shares of LifeVantage by 2.8% during the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company's stock worth $1,378,000 after purchasing an additional 6,121 shares in the last quarter. Hantz Financial Services Inc. bought a new stake in LifeVantage in the 2nd quarter valued at about $91,000. Renaissance Technologies LLC boosted its holdings in LifeVantage by 2.1% in the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company's stock worth $5,490,000 after acquiring an additional 17,300 shares in the last quarter. Finally, Ritholtz Wealth Management grew its stake in LifeVantage by 62.0% in the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company's stock valued at $346,000 after acquiring an additional 10,974 shares during the period. 35.32% of the stock is currently owned by institutional investors.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.